Galera Therapeutics, Inc. (GRTX)
USD 0.03
(-2.17%)
USD 0.03
(-2.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -44.84 Million | -43.42 Million | -67.95 Million | -59.53 Million | -46.66 Million | -22.16 Million |
| Net Income | -59.08 Million | -62.22 Million | -80.53 Million | -74.21 Million | -51.93 Million | -23.67 Million |
| Depreciation & Amortization | 259 Thousand | 114 Thousand | 778 Thousand | 368 Thousand | 267 Thousand | 127 Thousand |
| Deferred income taxes | -51.05 Million | -70 Thousand | - | -16 Thousand | 232 Thousand | - |
| Stock-based compensation | 5.56 Million | 7.16 Million | 7.23 Million | 5.53 Million | 2.39 Million | 865 Thousand |
| Change in working capital | -2.92 Million | 17 Thousand | -2.62 Million | 3.91 Million | -655 Thousand | 298 Thousand |
| Other non-cash items | 62.39 Million | 11.57 Million | 7.19 Million | 4.88 Million | 3.03 Million | 220 Thousand |
| Investing Cash Flow | 27.29 Million | 23.99 Million | 5.23 Million | 36.54 Million | -27.82 Million | -59.03 Million |
| Investments in PPE | -59 Thousand | -25 Thousand | -283 Thousand | -457 Thousand | -633 Thousand | -347 Thousand |
| Acquisitions | -27.35 Thousand | -24.01 Thousand | -5521.00 | -37 Thousand | 27.19 Thousand | - |
| Investment purchases | -22.64 Million | -59.89 Million | -71.97 Million | -67.74 Million | -123.19 Million | -71.19 Million |
| Sales/Maturities of investments | 49.99 Million | 83.91 Million | 77.5 Million | 104.75 Million | 96 Million | 12.5 Million |
| Other Investing Activities | 27.35 Thousand | 24.01 Thousand | 5521.00 | 37 Thousand | -27.19 Thousand | -58.68 Million |
| Financing Cash Flow | 31.49 Million | 3.88 Million | 66.7 Million | 20.5 Million | 78.03 Million | 89.84 Million |
| Debt repayment | - | - | -57.5 Million | -20 Million | -20 Million | -20 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 31.49 Million | 3.8 Million | 7.94 Million | 506 Thousand | 58.02 Million | 69.84 Million |
| Other Financing Activities | 3.89 Million | 81 Thousand | 116.26 Million | 40 Million | 40.01 Million | 89.84 Million |
| Accounts receivables | -104 Thousand | -258 Thousand | -307 Thousand | - | 629 Thousand | -363 Thousand |
| Accounts payables | -2.2 Million | -1.46 Million | -101 Thousand | 1.2 Million | 77 Thousand | 1.58 Million |
| Inventory | - | 258 Thousand | 307 Thousand | - | -629 Thousand | - |
| Other working capital | -617 Thousand | 1.48 Million | -2.52 Million | 2.71 Million | -732 Thousand | -1.28 Million |
| Cash at beginning of period | 4.31 Million | 19.85 Million | 15.87 Million | 18.35 Million | 14.81 Million | 6.16 Million |
| Cash at end of period | 18.25 Million | 4.31 Million | 19.85 Million | 15.87 Million | 18.35 Million | 14.81 Million |
| Capital Expenditure | -59 Thousand | -25 Thousand | -283 Thousand | -457 Thousand | -633 Thousand | -347 Thousand |
| Effect of forex changes on cash | 8.41 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 13.94 Million | -15.54 Million | 3.98 Million | -2.48 Million | 3.54 Million | 8.64 Million |
| Free Cash Flow | -44.9 Million | -43.45 Million | -68.24 Million | -59.99 Million | -47.29 Million | -22.51 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.06 Million | -4.38 Million | -5.58 Million | -59.08 Million | -15.07 Million | -20.71 Million |
| Depreciation & Amortization | 6000.00 | 9000.00 | 215 Thousand | 259 Thousand | 12 Thousand | 12 Thousand |
| Deferred income taxes | - | - | -3.95 Million | -51.05 Million | - | -72 Thousand |
| Stock-based compensation | 723 Thousand | 875 Thousand | 1.18 Million | 5.56 Million | 1.39 Million | 1.52 Million |
| Change in working capital | 618 Thousand | -1.29 Million | -6.43 Million | -2.92 Million | -937 Thousand | 860 Thousand |
| Other non-cash items | - | 1.22 Million | 4.66 Million | 62.39 Million | 2.08 Million | 7.64 Million |
| Investing Cash Flow | - | - | 3.97 Million | 27.29 Million | 10.46 Million | 7.54 Million |
| Investments in PPE | - | - | -9000.00 | -59 Thousand | - | -50 Thousand |
| Acquisitions | - | - | -3984.00 | -27.35 Thousand | - | -7599.00 |
| Investment purchases | - | - | -16 Thousand | -22.64 Million | -4.03 Million | -6.15 Million |
| Sales/Maturities of investments | - | - | 4 Million | 49.99 Million | 14.49 Million | 13.75 Million |
| Other Investing Activities | - | - | 3984.00 | 27.35 Thousand | 10.46 Thousand | 7599.00 |
| Financing Cash Flow | - | - | -232 Thousand | 31.49 Million | 2.13 Million | 1.81 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -232.00 | - | - | - |
| Common Stock Issuance | - | - | -232 Thousand | 31.49 Million | 1.93 Million | 1.81 Million |
| Other Financing Activities | - | - | 3.51 Million | 3.89 Million | 201 Thousand | 1812.00 |
| Accounts receivables | - | - | - | -104 Thousand | - | - |
| Accounts payables | -234 Thousand | -329 Thousand | -2.34 Million | -2.2 Million | -1.8 Million | -421 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 852 Thousand | -965 Thousand | -4.09 Million | -617 Thousand | 864 Thousand | 1.28 Million |
| Cash at beginning of period | 13.46 Million | 18.25 Million | 24.42 Million | 4.31 Million | 24.35 Million | 25.73 Million |
| Cash at end of period | 10.74 Million | 13.46 Million | 18.25 Million | 18.25 Million | 24.42 Million | 24.35 Million |
| Capital Expenditure | - | - | -9000.00 | -59 Thousand | - | -50 Thousand |
| Effect of forex changes on cash | - | - | 13.17 Million | 8.41 Million | - | -13.17 Million |
| Net cash flow / Change in cash | -2.71 Million | -4.79 Million | -6.17 Million | 13.94 Million | 77 Thousand | -1.38 Million |
| Free Cash Flow | -2.71 Million | -4.79 Million | -9.92 Million | -44.9 Million | -12.52 Million | -10.79 Million |
000637
SKLT
VINEETLAB
0355
RDOIF
FOM